Kevin A. Pokornowski

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 810 citations · Full text

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2004 · 537 citations · Full text

Vaccination, Clinical Emergence, Health Sciences +15

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Richard J. Colonno, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2006 · 347 citations · Full text

Diagnostic Virology, Hbv Replication, Hepatology +15

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

[781] FOUR YEAR ASSESSMENT OF ETV RESISTANCE IN NUCLEOSIDE-NAIVE AND LAMIVUDINE REFRACTORY PATIENTS

Richard Colonno, R.E. Rose, Kevin A. Pokornowski et al. · Journal of Hepatology · 2007 · 115 citations

Medicine, Resistance Mutation (Virology), Drug Resistance